J. DORE ;
B. TURNIPSEED ;
S. DWYER ;
A. TURNIPSEED ;
J. ANDRIES ;
G. ASCANI ;
C. MONNETTE ;
A. HUIDEKOPER ;
N. STRAUSS ;
P. WOLFSON
|
2019
Dans Journal of Psychoactive Drugs (Vol.51, n°2, April-June 2019) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.51, n°2, April-June 2019) Article : Périodique
Currently, ketamine is the only legal psychedelic medicine available to mental health providers for the treatment of emotional suffering. Over the past several years, ketamine has come into psychiatric use as an intervention for treatment resist[...]
Historique